Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells by Tsai, Fu-Ming et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Cell Biology
Open Access Research article
Induction of apoptosis by the retinoid inducible growth regulator 
RIG1 depends on the NC motif in HtTA cervical cancer cells
Fu-Ming Tsai1,2, Rong-Yaun Shyu3, Su-Ching Lin1, Chang-Chieh Wu4 and 
Shun-Yuan Jiang*1
Address: 1Department of Research, Buddhist Tzu Chi General Hospital Taipei Branch, Taipei county 231, Taiwan, Republic of China, 2Department 
of Microbiology, Soochow University, Shih Lin, Taipei 111, Taiwan, Republic of China, 3Department of Internal Medicine, Buddhist Tzu Chi 
General Hospital Taipei Branch, Taipei county 231, Taiwan, Republic of China and 4Department of Surgery, Tri-Service General Hospital, Taipei 
114, Taiwan, Republic of China
Email: Fu-Ming Tsai - afu2215@gmail.com; Rong-Yaun Shyu - ryshyu866@gmail.com; Su-Ching Lin - catherinelin@ms30.url.com.tw; Chang-
Chieh Wu - eric@ndmctsgh.edu.tw; Shun-Yuan Jiang* - jiang.shunyuan@gmail.com
* Corresponding author    
Abstract
Background: Retinoid-inducible gene 1 (RIG1), also known as tazarotene-induced gene 3 or
retinoic-acid receptor responder 3, is a growth regulator, which induces apoptosis and
differentiation. RIG1 is classified into the NC protein family. This study investigated functional
domains and critical amino acids associated with RIG1-mediated cell death and apoptosis.
Results: Using enhanced green fluorescence protein (EGFP)-tagged RIG1 variants, RIG1 proteins
with deletion at the NC domain significantly decreased cell death induced by RIG1, and fusion
variants containing only the NC domain significantly induced apoptosis of HtTA cervical cancer
cells. The EGFP-RIG1-induced apoptosis was significantly decreased in cells expressing N112C113
motif double- (NC→FG) or triple- (NCR→FGE) mutated RIG1 variants. Using dodecapeptides,
nuclear localization and profound cell death was observed in HtTA cells expressing wild type
RIG1111–123 or Leu121-mutated RIG1111–123:L→ C peptide, but peptides double- or triple-mutated
at the NC motif alone, RIG1111–123:NC→FG or RIG1111–123:NCR→FGE, were cytoplasmically
localized and did not induce apoptosis. The RIG1111–123 also induced apoptosis of A2058 melanoma
cells but not normal human fibroblasts.
Conclusion: The NC domain, especially the NC motif, plays the major role in RIG1-mediated pro-
apoptotic activity. The RIG1111–123 dodecapeptide exhibited strong pro-apoptotic activity and has
potential as an anticancer drug.
Background
Retinoid-inducible gene 1 (RIG1) [1], which encodes a pro-
tein of 164 amino acids also known as tazarotene-induced
gene 3 (TIG3) [2] or retinoic-acid receptor responder 3
(RARRES3) [3], belongs to the HREV107 gene family that
contains five members in humans [4-6]. Proteins of the
HREV107 family share four conserved domains, a pro-
line-rich motif located at the N-terminus, followed by a
conserved H-box, the NC domain and a C-terminal trans-
membrane domain [6-8]. The HREV107 family proteins
are growth regulators, and have recently been classified
into the NC protein family along with the lecithin:retinol
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acyltransferase (LRAT), protein 2A from Avian encephalo-
myelitis virus and Echovirus 22 and a hypothetical pro-
tein At5g16360 from Arabidopsis thaliana [6,8].
HREV107 family proteins are typically localized within
the endomembranes, such as the endoplasmic reticulum
(ER) and Golgi apparatus [9-13]. However, nuclear local-
ization has been reported for the HREV107 proteins
[11,14].
RIG1 exhibits growth suppressive and proapoptotic activ-
ities in normal keratinocytes [13] and cancer cells of vari-
ous origins [10,12,15,16]. The proapoptotic activities of
RIG1 are mediated through caspase-dependent [12] or -
independent pathways [13], and are initiated only by the
Golgi-, but not the ER-targeted RIG1 [12]. In addition,
RIG1 stimulates cellular differentiation of keratinocytes,
which is mediated by the activation of type I tissue trans-
glutaminase [13,17,18]. Also, RIG1 inhibits the signaling
pathways of Ras and phosphoinositide-3 kinase (PI3K)/
serine/threonine-specific protein kinase (AKT)
[12,19,20].
The structure/function relationship of RIG1 has been
investigated. Presence of the C-terminal transmembrane
domain, ranging from 134 to164 amino acids, that targets
the protein to endomembranes is essential for RIG1-
mediated activities [10,12,13,17-19]. The RIG1 segment
spanning amino acids 124–164 interacts with and serves
as the substrate of tissue transglutaminase I [18]. Also, the
N-terminal 124 amino acid region is required for RIG1-
dependent keratinocyte differentiation, and removal of
the region converts RIG1 into a proapoptotic protein in
human keratinocytes. Within the NC domain, the Asp112-
Cys113 (NC) motif of RIG1 is the most conserved feature
throughout evolution from virus to Homo sapiens [7], and
the Cys161 of LRAT, corresponding to the Cys113 of the
RIG1, is proposed to participate in a catalytic triad that is
directly involved in the LRAT-catalyzed esterification [21].
Recently, dodecapeptides (DPs) H-TIG-3111–123 and H-
Ha-Rev107-1111–123, based on 12 conserved amino acids
surrounding the NC motif within the NC domain of RIG1
and HREV107, have been shown to induce apoptosis of
melanoma cells, and the Leu120 has been shown to be
indispensable for this activity [22]. The H-TIG-3111–123,
which is referred to as RIG1111–123 hereafter, is targeted to
the nucleus where it binds and activates promoters of
transcription factors involved in the G1 → S transition.
The nuclear localization and DNA binding activities of
RIG1111–123 sharply contrasts with the character of wild
type RIG1 that is predominantly localized in the cyto-
plasm and binds to RAS [12,19] and transglutaminase
[13,17,18]. The function of the proline-rich region and H-
box of RIG1 has not been investigated, although the pro-
line-rich region of HREV107 has recently been shown to
bind PR65α, a subunit of the protein phosphatase 2A, and
to inhibit the enzyme's activity [23].
This study investigated functional regions and critical
amino acids that are essential for the proapoptotic activi-
ties of RIG1 in HtTA cervical cancer cells. Both full-length
RIG1 and various truncated variants were constructed
with an enhanced green fluorescence protein (EGFP) tag
to the N-terminus of the protein. Because RIG1111–123 also
functions as an anti-proliferative peptide [22], and to fur-
ther evaluate critical amino acids responsible for RIG1111–
123- and RIG1-mediated activities, wild type and mutated
(Asp112, Cys113, Leu120 and Arg121) DPs as well as the full
length RIG1 containing various mutations tagged to the
C-terminal of EGFP were constructed. The NC motif was
selected due to its evolutionary conservation from virus to
mammalian [7]. Leu120 is shown to play a critical role in
the RIG1111–123-mediated activities in E:WM-115
melanoma cells, and Arg121 may play a role involving
DNA contacts [22]. Therefore, Leu120  and Arg121  were
selected for the analysis. The results demonstrate that the
NC motif of RIG1 is important for RIG1-mediated cell
death. In addition, the NC motif, but not Leu120 is essen-
tial for RIG1111–123-mediated induction of cell death of
HtTA cells.
Results
The NC domain is important for RIG1 in the induction of 
cell death and apoptosis
To identify functional domains of RIG1 which are related
to induction of cell death or apoptosis, we first con-
structed expression vectors that synthesized recombinant
proteins containing EGFP tagged to the N-terminus of the
wild type RIG1 or various truncated RIG1 variants, with
the exception of RIG1ΔC in which EGFP was tagged to the
C-terminus of the RIG1 (Fig 1A). The RIG1ΔN1,
RIG1ΔN2, RIG1ΔN3 and RIG1ΔN40–136 variant pro-
teins all contained the membrane spanning domain but
differed in the H-box and NC domains. The C-terminal
deleted RIG1ΔN4, RIG1/NC and RIG1ΔC proteins vary in
the N-terminal 40 amino acids including the H-box.
Expression of EGFP-tagged RIG1 variants at the expected
molecular weight was demonstrated in transfected
cytosols prepared from HtTA cervical cancer cells (Fig 1B).
The EGFP-tagged wild type and N-terminal truncated
(RIG1ΔN1, RIG1ΔN2, and RIG1ΔN3) RIG1 recombinant
proteins were expressed at much lower levels compared to
that of variants without C-terminal hydrophobic domain.
Similar results were also observed in previous studies
[12,18,19]. With the exception of RIG1ΔN1 and
RIG1ΔN2, which had mainly nuclear localization with
weak and diffuse cytoplasmic distribution, all the EGFP-
tagged recombinant proteins that contained the C-termi-
nal hydrophobic domain and the N-terminal region
between 27 and 39 amino acids (RIG1, RIG1ΔN3 and
RIG1Δ40–136) were primarily distributed in the perinu-
clear region (Fig 1C), and were partially co-localized to
the Golgi apparatus [see Additional file 1]. The C-terminal
truncated RIG1 with EGFP tagged to either the C-BMC Cell Biology 2009, 10:15 http://www.biomedcentral.com/1471-2121/10/15
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(RIG1ΔC-EGFP) or N-terminus [10] were diffusely
expressed throughout the nucleus and cytoplasm. Vari-
ants (EGFP-RIG1ΔN4 and EGFP-RIG1/NC) that had trun-
cation at both the N- and C-termini exhibited similar
expression patterns as the RIG1ΔC-EGFP with the excep-
tion of perinuclear localization of the fusion proteins also
detected in less than 5% of cells.
Cell death and viability, determined by measuring the
release of lactate dehydrogenase (LDH) and by the MTT
assay respectively, were then analyzed in HtTA cells tran-
siently transfected with various deleted EGFP-RIG1
expression vectors. With the exception of RIG1ΔC-EGFP
that had no effect on cell death and cell viability, wild type
and the other EGFP-RIG1 deletion variants significantly
Analysis of the expression of various truncated EGFP-RIG1 fusion proteins Figure 1
Analysis of the expression of various truncated EGFP-RIG1 fusion proteins. (A) Schematic diagram of RIG1 expres-
sion vectors that express wild type or various truncated RIG1 proteins. (B) Western blot analysis of the truncated EGFP-
tagged RIG1 fusion proteins. HtTA cells plated in 6-cm dishes were transiently transfected with 1.5 μg of indicated expression 
vectors for 24 h. Fifty μg of cellular proteins were resolved by 15% SDS-PAGE. Expression of RIG1 variants was detected using 
anti-myc or anti-EGFP antibodies. (C) Subcellular localization of EGFP-tagged RIG1 variants. Cells were transiently transfected 
with indicated expression vectors for 18 h. Cells were fixed and analyzed with a laser scanning confocal microscope. Scale bar: 
5 μm; wt: wild type.BMC Cell Biology 2009, 10:15 http://www.biomedcentral.com/1471-2121/10/15
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increased cell death by 29%–115% and reduced cell via-
bility by 22–39% after transient expression for 48 h (Fig
2A), and the EGFP-RIG1Δ40–136, which lacks the NC
domain, had the weakest effect on both cell death and cell
viability among the RIG1 fusion proteins tested. In con-
trast, the EGFP-tagged RIG1 variant that contained only
the NC domain (EGFP-RIG1/NC) significantly increased
cell death by 82% and reduced cell viability by 36%. Sim-
ilar effects of wild type and truncated RIG1 variants on cell
growth were also observed in HtTA cervical cancer cells
expressing the monomer red fluorescence protein
(MRFP)-tagged recombinant RIG1 variants (data not
shown), indicating the effects on cell growth was medi-
ated by RIG1 fragment within the recombinant protein.
The effects of EGFP-tagged recombinant RIG1 variants on
cell death were further explored by the analysis of chroma-
tin condensation in HtTA cells 48 h after transfection.
Chromatin condensation was readily detected in most
cells expressing the EGFP-tagged wild type or truncated
RIG1 with the exception of RIG1ΔC-EGFP and EGFP-
RIG1Δ40–136 (Fig 2B). These results suggest that the NC
domain plays the major role in the growth inhibition and
proapoptotic activities of RIG1.
Whether induction of cellular apoptotosis by RIG1 vari-
ants in HtTA cells was related to caspase 3 activation was
then analyzed in cytosol extracts prepared 24 h after trans-
fection. Caspase 3 activities in cytosol extracts prepared
from EGFP-tagged recombinant RIG1 variants that con-
tained the C-terminal hydrophobic domain (RIG1,
RIG1ΔN1, RIG1ΔN2 and RIG1ΔN3) were significantly
enhanced ranging from 205 to 227% of control levels (Fig
2C). However, RIGIΔC-EGFP, EGFP-RIG1Δ40–136,
EGFP-RIG1ΔN4 and EGFP-RIG1/NC did not activate cas-
pase 3 in HtTA cells.
The NC motif plays a critical role in DP-induced cell death 
and apoptosis
A multiple alignment of amino acid sequences of the NC
domain among the HREV107 family proteins and LRAT is
shown in Fig 3A. Thirteen amino acids within the NC
domain are identical among all 6 members, and the DP
region exhibits the highest degree of homology. Fluores-
cein (FITC)-labeled wild type and mutated RIG1111–123
peptides (Fig 3B) were introduced into HtTA cells to ana-
lyze activities and critical amino acids of DP affecting cell
death. The wild type FITC-RIG1111–123 was predominantly
distributed within the nucleus of HtTA cells 48 h after
electroporation (Fig 4A). The Leu120-mutated FITC-
RIG1111–123:L  → C was distributed homogenously
between cytoplasm and nucleus. In contrast, DPs contain-
ing mutation at one (R), two (NC) or three (NCR) amino
acids were all cytoplasmically localized. Similar nuclear
and cytoplasm distribution of wild type and NCR-
mutated RIG1111–123 respectively was observed in A2058
melanoma cells. However, both the wild type and NCR-
mutated RIG1-DPs were distributed only within the cyto-
plasm of normal human fibroblasts (Fig 4B, C). In addi-
tion to nuclear targeting, RIG1111–123 also induced nuclear
shrinkage, a characteristic of cellular apoptosis, of A2058
cells.
Analysis of FITC-DPs effect on cell death showed that wild
type FITC-RIG1111–123 significantly increased cell death by
67% and decreased cell viability by 34% 48 h after peptide
introduction in HtTA cells, and the effects were also signif-
icantly evident 24 h after peptide introduction (Fig 5A).
Similarly, the Leu120 or Arg121 mutated FITC-DPs both sig-
nificantly increased cell death by 64–89% and decreased
cell viability by 29–37% 48 h after peptide introduction.
FITC-DPs that contained two (NC) or three (NCR) amino
acid mutations had no effect on cell death and cell viabil-
ity. Unrelated peptide (FITC-GYFHEGFHGYFGY) [22]
was also tested for the activity on cell death and cell via-
bility 24 and/or 48 h after peptide introduction, and no
effect was observed (data not shown). Similar effects on
cell death and viability mediated by the wild type but not
NCR-mutated FITC-RIG1111–123 were observed in A2058
melanoma cells but not in normal human fibroblasts (Fig
5B). Activities of FITC-DPs on chromatin condensation
were also analyzed in HtTA cells. Chromatin condensa-
tion was observed only in cells electroporated with wild
type, Leu120-mutated or Arg121-mutated FITC-DPs, but not
in cells with NC- or NCR-mutated FITC-DPs (Fig 5C).
Similarly, fusion protein containing RIG1111–123 tagged to
the C-terminus of EGFP (EGFP-RIG1111–123) [see Addi-
tional file 2] induced cellular chromatin condensation,
and significantly induced cell death of HtTA cells as deter-
mined by MTT and LDH assay [see Additional file 3], and
the RIG1111–123-mediated cell death and apoptosis is
reversed by mutation at the NC motif, but not at Leu120 or
Arg121 within the EGFP-tagged DP. Finally, cytosol extracts
prepared from HtTA cells electroporated with FITC-conju-
gated DPs for 24 h were analyzed for caspase 3 activation,
and no caspase 3 activation was detected in all cytosol
extracts (data not shown).
Mutation at the NC motif reduces RIG1-mediated cell 
death
To further characterize the significance of amino acids
within the DP in RIG1-mediated cell death and cell viabil-
ity in HtTA cells, we constructed constitutive EGFP-RIG1
expression vectors that synthesized wild type RIG1 or
RIG1 with single (R → E or L → C), double (NC → FG) or
triple (NCR → FGE) amino acid substitution. Proper
expression of mutated EGFP-RIG1 fusion proteins in
HtTA cells was confirmed by Western blotting (Fig 6A).
Expression of wild type EGFP-RIG1 for 24 or 48 h resulted
in significant increase of cell death by 57 or 83%, respec-
tively, and reduction of cell viability by 22 or 29%, respec-BMC Cell Biology 2009, 10:15 http://www.biomedcentral.com/1471-2121/10/15
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Truncated EGFP-RIG1 fusion proteins induced cell death and apoptosis Figure 2
Truncated EGFP-RIG1 fusion proteins induced cell death and apoptosis. (A) HtTA cells were transfected with 0.3 
μg of indicated recombinant RIG1 expression vectors for 24 or 48 h. Cell death was detected by measuring LDH release and 
cell viability was measured using the MTT method. Representative results of three independent experiments are shown and 
are expressed as means and standard errors of the means after normalization to the control group. (B) Cells were transfected 
with indicated expression vectors for 48 h. Cells were stained with Hoechst 33258 dye, and chromatin condensation was eval-
uated with a fluorescent microscope. Arrows indicate cells expressing the EGFP or RIG1 fusion protein that were positive for 
chromatin condensation. Scale bar: 1 μm. (C) Cells were transfected with indicated expression vectors for 24 h. The activation 
of caspase-3 was assayed using the colorimetric substrate Ac-DEVD-pNA. wt: wild type; Student t test: *, P < 0.05; **, P < 0.01; 
***, P < 0.001.BMC Cell Biology 2009, 10:15 http://www.biomedcentral.com/1471-2121/10/15
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tively (Fig 6B). Expression of Leu120 substituted EGFP-
RIG1 for 24 or 48 h resulted in significant increase of cell
death by 56 or 89%, respectively, and reduction of cell via-
bility by 24 or 26%, respectively. Mutation at Leu120 did
not reduce EGFP-RIG1-mediated cell death or cell viabil-
ity. Significant effects of the Arg121 substituted EGFP-RIG1
on cell death and cell viability were observed both at 24
and 48 h after transfection, although the effect was weaker
than that of EGFP-RIG1. Increase of cell death and
decrease in cell viability in EGFP-RIG1 variant transfect-
ants containing double (NC → FG) or triple (NCR →
FGE) mutations were not evident until 48 h after transfec-
tion with maximal 37% increase of cell death and 17%
reduction of cell viability. The effects of double or triple
amino acid substitutes were significantly less than the
effects induced by EGFP-RIG1, indicating that the NC
motif of RIG1 is important for the effects of RIG1 on cell
death. Similar to the results shown in the Fig 5C, chroma-
tin condensations as observed in cells expressing the
EGFP-RIG1 were profoundly decreased in cells expressing
double (NC → FG) or triple (NCR → FGE) mutated EGFP-
RIG1 variants. Leu120 and Arg121 substitution had no effect
on or had weakly reduced EGFP-RIG1-induced chromatin
condensation of HtTA cells (data not shown).
Designation of mutated DP of HREV107 family protein Figure 3
Designation of mutated DP of HREV107 family pro-
tein. (A) Sequence alignment of the NC domains of human 
HREV107 family proteins and LRAT. Identical amino acids 
are indicated by black boxes and the DP is underlined. (B) 
Comparison of amino acid sequences of DP and DP varia-
tions (changed amino acids underlined) used in this study. 
Sequences of DPs derived from HREV107 and LRAT are also 
indicated.
Subcellular localization of FITC-DPs Figure 4
Subcellular localization of FITC-DPs. HtTA (A), A2058 
cells and normal human fibroblasts (B and C) plated in 6-well 
plates overnight were electroporated with 5 μM of the indi-
cated FITC-labeled DPs and then incubated for 48 h. Cells 
were fixed, stained with DAPI, and analyzed with a laser 
scanning confocal microscope. Scale bar: 5 μm.
FITC-DPs induced cell death and apoptosis Figure 5
FITC-DPs induced cell death and apoptosis. HtTA (A 
and C), A2058 (B) cells and normal human fibroblasts (B) 
were electroporated with 5 μM of the indicated FITC-labeled 
DPs or with medium only (control). Cells were washed and 
incubated for 24 and 48 (A) or for 48 (B and C) h. Cell death 
was detected by measuring LDH release and cell viability was 
measured with the MTT method (A and B). Representative 
results of three independent experiments are shown and are 
expressed as means and standard errors of the means after 
normalization to the control group. Student t test: **, P < 
0.01; ***, P < 0.001. (C) Cells were stained with the Hoechst 
33258 dye, and chromatin condensation was evaluated with a 
fluorescent microscope. Arrows indicate that cells express-
ing the FITC-conjugated peptide and were positive for chro-
matin condensation. Scale bar: 5 μm.BMC Cell Biology 2009, 10:15 http://www.biomedcentral.com/1471-2121/10/15
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Discussion
Through expression of EGFP-tagged RIG1 variants, we
have identified that the NC domain, especially the NC
motif, plays the most profound role in the RIG1-mediated
growth inhibition and cellular apoptosis of HtTA cells.
The conclusion is supported first by significantly
decreased the effect of RIG1 on cell death of the fusion
protein (RIG1Δ40–136) with deletion at the NC domain,
and fusion proteins that contain only the NC domain
(RIG1/NC) exhibit profound proapoptotic activity. In
addition, we demonstrated that the RIG1111–123 within the
NC domain increases cell death of HtTA cells, and that
mutation of the NC motif results in complete abolish-
ment of this activity. The importance of the NC motif is
further demonstrated by the significant decrease of cell
death in cells expressing the recombinant RIG1 variants
that have two (NC) or three (NCR) amino acid mutations.
Significance of the NC motif in RIG1 function is sup-
ported by the evolutionary conservation of the motif
[6,7]. Although a decrease of RIG1 expression was fre-
quently observed in several types of cancer tissues [24-27],
no mutation at the NC motif of RIG1 has been reported.
Analysis of the structure/function relationship of the NC
motif and adjacent amino acids has been very limited.
Mondal and coworkers first demonstrated that both
cysteine residues within the DP of LRAT (LRAT159–171) (Fig
3B) are important for its enzymatic activity, and that the
cysteine in the NC motif is the critical active-site involved
in catalysis [28]. Consistent with previous observations
that demonstrate proapoptotic activities of DPs derived
from HREV107 and RIG1 in melanoma cells (Fig 4B) [22],
we show that RIG1111–123 induces cell death when intro-
duced into HtTA cervical cancer cells as either a FITC-con-
jugated peptide or an EGFP fusion protein. In contrast to
the significant role of Leu120  in RIG1111–123-mediated
growth inhibition of E:WM-115 melanoma cells [22], this
study demonstrated that the NC motif is indispensable,
the Arg121 residue plays a minor role and the Leu120 has no
effect on the anti-proliferative activities of RIG1111–123 in
HtTA cells. This conclusion is supported first by FG for NC
substitution which resulted in complete or significantly
loss of anti-proliferative activities of FITC-RIG1111–123 or
EGFP-RIG1111–123 respectively, second by profound loss
of anti-proliferative activities in NC or NCR mutated RIG1
fusion proteins, third by reduced proapoptotic activities
of the Arg121mutated RIG1111–123 and RIG1, and fourth by
the lack of effect of Leu120 mutation on proapoptotic activ-
ities induced by RIG1111–123 or RIG1. In addition to HtTA
cervical cancer cells, results from this and previous [22]
studies also show growth suppressive activities of
RIG1111–123  on established or primary culture of
melanoma cells but not normal human fibroblasts and
proliferating melanocytes. Therefore, RIG1111–123 is selec-
tively toxic to tumor cells, and the significance of Leu120 in
the RIG1111–123-mediated growth suppression shown pre-
viously in melanoma cells is tumor cell type specific.
RIG1111–123 is predicted to have an alpha helical structure
[6,22], and selectively binds to cis-binding elements and
activates transcription factors involved in the G1/G0 → S
transition in melanoma cells [22]. In this study, we dem-
onstrated that RIG1111–123 is targeted to nuclei of sensitive
HtTA and A2058 cells, and mutations that render the loss
of growth inhibitory activities result in cytoplasmic distri-
bution of the DPs. Also, RIG1111–123 that has no effect on
normal fibroblasts is distributed only within the cyto-
plasm. The tight association between nuclear localization
and growth suppressive activities of RIG1111–123 supports
the notion that RIG1111–123-mediated cell death in sensi-
tive tumor cells is likely to be mediated through sequence-
specific DNA binding that leads to alteration in gene
expression involved in the cell cycle and apoptosis.
Absence of nuclear localization of RIG1111–123 in resistant
melanoma cells [22] and normal human fibroblasts may
be related to failure in nuclear trafficking or to retention
of the peptide. The α-helical structure of RIG1111–123
within the EGFP-RIG1111–123  fusion protein is mostly
maintained predicted using SSpro and PSIPREDView pro-
grams. This supports the growth suppressive activity of
EGFP-RIG1111–123. In contrast to complete loss of activi-
Analysis of the expression and effects on cell growth of vari- ous mutated EGFP-RIG1 fusion proteins Figure 6
Analysis of the expression and effects on cell growth 
of various mutated EGFP-RIG1 fusion proteins. (A) 
Western blot analysis of the mutated EGFP-RIG1 proteins. 
HtTA cells plated in 6-cm dishes were transiently transfected 
with 1.5 μg of indicated expression vector for 24 h. (B) 
Mutated EGFP-RIG1 fusion proteins induced cell death. 
HtTA cells were transfected with 0.3 μg of the control EGFP 
or indicated EGFP-tagged wild type or mutated RIG1 expres-
sion vectors for 24 or 48 h. Cell death was detected by 
measuring LDH release, and cell viability was measured with 
the MTT method. Representative results of three independ-
ent experiments are shown and are expressed as means and 
standard errors of the means after normalization to the con-
trol group. wt, wild type; Student t test: *, P < 0.05; **, P < 
0.01; ***, P < 0.001.BMC Cell Biology 2009, 10:15 http://www.biomedcentral.com/1471-2121/10/15
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ties in NC- or NCR-mutated DPs, growth suppressive
activities of the NC- or NCR-mutated EGFP-DP fusion
proteins were significantly, but not completely, reduced.
The increase in nuclear localization of the double and tri-
ple mutated EGFP-DPs, as compare to that of FITC-conju-
gated DPs, may be related to partial growth suppressive
activities of the mutated EGFP-DPs. Currently, critical
amino acids involving the binding of RIG1111–123 to cis
transcription elements have not been addressed, although
RIG1111–123 has been shown to bind cis binding elements
for receptors of retinoic acids [22]. The fact that nuclear
distribution of RIG1111–123 was completely disrupted by
mutations at the NC motif or Arg121, and was only par-
tially altered by Leu120 mutation suggests that the NC
motif and Arg121 play a profound role and Leu120 a minor
role in the binding of RIG1111–123 to cis-elements. In addi-
tion to the four amino acids investigated in this study, six
amino acids (EHFV–YG) within RIG1111–123 are conserved
across the HREV107 protein family and LRAT (Fig 3A).
Further analysis using site-directed DP mutants will be
useful in dissecting the role of the NC motif, Arg121, Leu120
and other six conserved amino acids in the DNA binding
properties as well as regulation of promoter and growth
suppressive activities of RIG1111–123.
RIG1ΔN4 and RIG1ΔC are different only by 20 amino
acids at the N-terminus, which consist of the proline-rich
region. RIG1ΔN4 that is devoid of the proline-rich region
inhibits growth and induces apoptosis of HtTA cells.
However, RIG1ΔC fails to have effect on cell growth,
apoptosis and activation of Ras and tissue transglutami-
nase I when the truncated protein is expressed as fusion
proteins that have myc or EGFP tagged to the N- or C-ter-
minus [10,12,13,18,19]. These results suggest that the N-
terminal proline-rich region of RIG1 may bind effectors
that prevent RIG1ΔC from exerting effects on the regula-
tion of cell growth and apoptosis. Truncation of the N-ter-
minal region, as demonstrated in RIG1ΔN4, restores these
activities. In fact, the proline-rich region of HREV107 has
recently been shown to bind a subunit of the protein
phosphatase 2A, PR65α. The binding leads to inhibiting
the enzyme's activity and is important for proapoptotic
activities of HREV107 on ovarian cancer cells [23]. Identi-
fication of a binding protein for the proline-rich region of
RIG1 will be important to delineate the functional
domain at the extreme N-terminus of RIG1.
Most results from previous studies demonstrate perinu-
clear and endomembrane localization of transfected wild
type RIG1, HREV107 and HRASLS, which induce cellular
apoptosis and/or differentiation of normal and cancer
cells [9,12-14,18]. However, nuclear localization of
HREV107 and RIG1 was also observed in fibroblasts and
cancer cells, and cytoplasmic but not nuclear targeted
HREV107 is related to growth stimulation and poor
patient survival of non-small cell lung cancer [11,14,24].
Therefore, proteins of this gene family may localize to
multiple intracellular compartments where they have dis-
tinct activities. Previous studies in HtTA cells and kerati-
nocytes have demonstrated that RIG1-induced apoptosis
or differentiation-related apoptosis is mediated through
Golgi apparatus or mitochondria via caspase 3-dependent
and/or -independent mechanisms [12,13]. Similarly, cas-
pase 3-mediated apoptosis is reported in keratinocytes
expressing RIG1 with 124 amino acids truncated at the N-
terminus [18]. Results of this study in HtTA cells also
demonstrated activation of caspase 3 during apoptosis
induced by variants (RIG1ΔN1, RIG1ΔN2 and RIG1ΔN3)
that contain the C-terminal hydrophobic domain but not
RIG1ΔN4 and RIG1/NC that are deleted at both N- and C-
termini. Although caspase 3 activation was observed in
RIG1ΔN1, RIG1ΔN2 and RIG1ΔN3, RIG1ΔN1 and
RIG1ΔN2 are mainly distributed in the nucleus whereas
RIG1ΔN3 is in the perinuclear region. Therefore, presence
of C-terminal hydrophobic domain rather than subcellu-
lar localization appears to play an important role in the
caspase 3 activation during apoptosis induced by N-termi-
nal truncated RIG1 variants. The nuclear targeted RIG1111–
123 that exhibits DNA binding and proapoptotic activities
was first demonstrated by Simmons et al. [22]. This study
further demonstrated that proapoptotic activities of trun-
cated RIG1 variants, RIG1ΔN4 and RIG1/NC, and the
nuclear targeted RIG1111–123 are mediated through the cas-
pase 3-independent mechanism in cervical cancer cells.
RIG1ΔN4 and RIG1/NC were found in both nucleus and
cytoplasm. Whether the mechanism of apoptosis induced
by RIG1ΔN4 and RIG1/NC is similar to that of RIG1111–
123 that is mediated through regulation of gene expression,
as proposed by Simmons et al [22], needs further investi-
gation.
Wild type RIG1 and N-terminal truncated variants such as
RIG1ΔN1, RIG1ΔN2 and RIG1ΔN3 were expressed at
much lower levels than RIG1ΔN4 and RIG1/NC that were
truncated at both N- and C-termini. Short protein half life
[19] or an increase in distribution to the particulate frac-
tion due to N-terminal truncation [18] may be responsi-
ble for the low protein levels observed in N-terminal
truncated RIG1 variants. Although expressed at low levels,
the extent of growth suppression on HtTA cells induced by
N-terminal truncated variants was relatively similar to the
RIG1ΔN4 and RIG1/NC. Similar potent proapoptotic
activities, despite being expressed at extremely low levels,
of RIG1 variants with N-terminal truncation for 112 to
124 amino acids were also reported in keratinocytes [18].
RIG1 is a growth regulator that suppresses cell growth
through induction of cellular differentiation and/or apop-
tosis. The differentiation-inducing activity of RIG1 on
keratinocytes is mediated through the activation of tissueBMC Cell Biology 2009, 10:15 http://www.biomedcentral.com/1471-2121/10/15
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transglutaminase I [13,17]. A structure/function analysis
has demonstrated that the N-terminal region of RIG1 is
required for pro-differentiation activities, regardless, the
C-terminal hydrophobic region by itself is enough for the
activation of tissue transglutaminase I [18]. Recently,
results from our [12,19] and others [20] studies in HtTA
cervical and ovarian cancer cells have demonstrated that
RIG1 inhibits expression and activation of signaling mol-
ecules such as HER2, RAS, PI3K/AKT and mTOR that are
involved in the regulation of cell growth, apoptosis and
tumor invasion. Further analysis using various truncated
and mutated RIG1 variants will be useful to dissect mech-
anisms as well as functional domains and critical motifs
of RIG1 in the regulation of signal pathways involving
growth factor receptors.
Conclusion
In summary, RIG1 variants exhibit growth inhibitory
activity both when localized to the nucleus and when
localized to the cytoplasm. The fact that caspase 3 activa-
tion was detected in N-terminal truncated variants, such
as RIG1ΔN1, RIG1ΔN2 and RIGΔN3, but not in C-termi-
nal truncated variants supports the existence of multiple
mechanisms during RIG1-mediated growth inhibition.
The NC domain, especially the NC motif, plays an impor-
tant role in RIG1-mediated apoptosis in HtTA cervical
cancer cells. RIG1111–123 alone exhibits profound proap-
optotic activities and appears to be useful for develop-
ment as an anticancer drug.
Methods
Expression vectors
The vectors pRIG1ΔC-EGFP, pRIG1-myc and pRIG1ΔC-
myc have been described previously [19]. Expression vec-
tors (pRIG1ΔN1-myc, pRIG1ΔN2-myc, pRIG1ΔN3-myc
and pRIG1ΔN4-myc, pRIG1Δ40–136) with deleted RIG1
variants containing myc and his epitopes were generated
by site-directed mutagenesis using a single primer as
described previously [29] (Fig. 1). Briefly, RIG1 deleted
plasmids were constructed by amplification of the pRIG1-
myc plasmid using primers for RIG1ΔN1 (5'-CAGAATTC-
CTTGGCTTCGAGATGCAACCACGGCCCGTGG-3'),
RIG1ΔN2 (5'-CAGAATTCCTTGGCTTCGAGATGAGT-
GAGTACCCCGGGGCTG-3'), RIG1ΔN3 (5'-
CAGAATTCCTTGGCTTCGAGATGTATATAGGAGAT-
GGCTACGTGATCCATC-3') and RIG1ΔN40–136 (5'-
GTGATCCATCTGGCTCCTCCAGTCGGTGTGGCCACG-
GCGCTTG-3'). The pRIG1ΔN4-myc plasmid was con-
structed by amplification of pRIG1ΔC-myc using the
primer (5'-AGAATTCCTTGGCTTCGAGATGTATGAG-
CAATGGGCCCTGTATATA-3'). To generate expression
vectors for EGFP-tagged (pEGFP-RIG1ΔN1, pEGFP-
RIG1ΔN2, pEGFP-RIG1ΔN3, pEGFP-RIG1ΔN4, and
pEGFP- RIG1Δ40–136) RIG1 variants, truncated RIG1
cDNA fragments were amplified from the respective myc-
and his-tagged plasmids described above using 5' (5'-
TCTCGAGTTCTTGGCTTCGAGATG-3') and 3' (5'-
CGGAATTCTCAATGATGATGATGATG-3') primers, and
then subcloned in-frame into XhoI-EcoRI sites of the
pEGFP-C1 vector (Clontech Laboratories, Inc, Palo Alto,
CA), respectively. The NC domain of the RIG1 cDNA frag-
ment (RIG1/NC) was amplified from pRIG1ΔN2-myc
using 5' (5'-AGAATTCCTTGGCTTCGAGATGAGTG-3')
and 3' (5'-GTGGATCCTTCAACCTTGGCCTTTTC-3')
primers and then subcloned in-frame into the pEGFP-C1
to generate pEGFP-RIG1/NC. To generate EGFP-tagged
and RIG1 mutated expression vectors (pEGFP-RIG1:NC
→ FG, pEGFP-RIG1:R → E, pEGFP-RIG1:L → C), mutated
RIG1 plasmids were generated via site-directed mutagene-
sis by amplification of the pEGFP-RIG1-myc using prim-
ers containing mutations at amino acids Asp112 and Cys113
(5'-CAGTATTGTGAGCAGGTTTGGCGAGCACTTTGT-
CACCCAGCTG-3'), Arg121  (5'-CTTTGTCACCCAGCT-
GGAGTATGGCAAGTCCCGCTGTAAACAG-3'), and
Leu120  (5'-GCACTTTGTCACCCAGTGTAGATAT-
GGCAAGTCCCGCTGTAAAC-3'). The pEGFP-RIG1:NCR
→ FGE was generated from pEGFP-RIG1:NC → FG using
primer (5'-CTTTGTCACCCAGCTGGAGTATGGCAAGTC-
CCGCTGTAAACAG-3'). The amplified plasmids contain-
ing the indicated mutations were then digested with DpnI
and transformed into the E. coli HB101 strain. The cDNA
sequences of RIG1 and the expression of fusion proteins
were confirmed by DNA sequencing and Western blot-
ting, respectively. Construction of expression vectors that
synthesized MRFP tagged RIG1 variants and EGFP tagged
DP recombinant proteins was described in supplementary
material [see Additional file 4].
Cell culture and transfection
HtTA cervical cancer cells (obtained from Dr. T.-C. Chang,
Department of Biochemistry, National Defense Medical
Center, Taiwan), A2058 melanoma cells and normal
human fibroblasts (Food Industry Research and Develop-
ment Institute, Taiwan) were maintained in RPMI-1640
medium supplemented with 25 mM HEPES, 26 mM
NaHCO3, 2 mM L-glutamine, penicillin (100 units/ml),
streptomycin (100 μg/ml), and 10% fetal bovine serum
(FBS) at 37°C in 5% CO2. Cells plated in culture dishes
were transfected with the expression vectors using lipo-
some mediated-transfection. Briefly, plasmids and lipo-
fectamine (Gibco BRL, Gaithersburg, MD) were diluted in
Opti-MEM medium and then mixed with plasmids at
room temperature for 15 min. The DNA-lipofectamine
complexes were then added to cells for 2.5 h at 37°C.
Cells were refreshed with complete medium for 24 h at
37°C for further analysis.
Electroporation
Cells were plated on coverslips in six-well plates at 1 × 105
cells per well in RPMI-1640 supplemented with 25 mMBMC Cell Biology 2009, 10:15 http://www.biomedcentral.com/1471-2121/10/15
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HEPES, 26 mM NaHCO3, 2 mM L-glutamine, penicillin
(100 units/ml), streptomycin (100 μg/ml), and 10% FBS
and incubated overnight. Cells were then washed, incu-
bated with 5 μM of the various FITC-labeled DPs, and
electroporated with four-square pulses (7 V) of 60-milli-
seconds duration with 50-milliseconds intervals from a
CUY21 pulse generator (Nepagene, Ichikawa, Chiba,
Japan). After electroporation, cells were washed twice
with medium and incubated at 37°C in 5% CO2 for 24 or
48 h.
Western blotting
Cells in a 6-cm dish were washed twice with ice-cold phos-
phate buffered saline (PBS, 3.2 mM Na2HPO4, 0.5 mM
KH2PO4, 1.3 mM KCl, 135 mM NaCl, pH 7.4) 24 h after
transfection and then lysed in 200 μl of MLB buffer (25
mM HEPES, pH 7.5, 150 mM NaCl, 1% Igepal CA-630, 10
mM MgCl2, 1 mM EDTA, 10% glycerol) containing pro-
tease inhibitors (20 μg/ml aprotinin, 20 μg/ml phenyl-
methylsulfonyl fluoride) and phosphatase inhibitors (2
mM NaF, 1 mM Na3VO4). After centrifugation at 14,000 ×
g for 5 min, the proteins in the lysates were quantitated
using the Bio-Rad Protein Assay Kit (Bio-Rad Laborato-
ries, Inc., Hercules, CA). Proteins (50 μg) were separated
on 15% SDS-polyacrylamide gels and transferred to poly-
vinylidene difluoride membranes. After the membranes
had been blocked, they were incubated first with anti-myc
(Invitrogen, Carlsbad, CA), anti-EGFP (Clontech), or anti-
actin antibody (Sigma, St Louis, MO) for 12 h at 4°C and
then with horseradish-peroxidase-conjugated goat anti-
mouse IgG antibody at room temperature for 1 h. An ECL
kit (Amersham, Buckinghamshire, UK) was used for the
substrate reaction.
Confocal microscopic analyses
Cells were plated on coverslips in six-well plates at 1 × 105
cells per well in RPMI-1640 containing 10% FBS and incu-
bated overnight. The cells were then transfected with 1 μg
of various RIG1 expression vectors for 18 h. The cells were
washed and fixed with 4% paraformaldehyde and then
analyzed with a Zeiss LSM510 laser scanning confocal
microscope (Carl Zeiss Jena GmbH, Jena, Germany).
Alternatively, the cells were electroporated with FITC-DPs
for 48 h. The cells were washed, fixed, stained with 1 μg/
ml 4'6-diamidino-2-phenylindole (DAPI), and then ana-
lyzed with a Leica TCS SP5 scanner (Leica, Bensheim, Ger-
many). Analysis the expression of MRFP-tagged wild type
and variants of RIG1 was the same as our previous study
[12]. The BODIPY@FLC5-ceramide-BSA was used to stain
trans-Golgi organelles. After stained with the DAPI dye,
the cells were analyzed with a Leica TCS scanner.
Analysis of cell death and apoptosis
Cells were plated in triplicate in 24-well plates at a density
of 2 × 104 cells per well in RPMI-1640 medium containing
10% FBS and incubated overnight. The cells were trans-
fected with 0.3 μg of various RIG1 expression vectors or
empty control vector and then refreshed with complete
medium immediately and 24 h after transfection. Cells
were analyzed for viability using the MTT assay as
described previously [12]. Cell viability relative to that of
control transfected cells was defined as [(A570–A660) of
RIG1-transfected cells/(A570–A660) of control trans-
fected cells] × 100%. Measurement of the release of LDH
using the Cytotoxicity Detection Kit (Roche Molecular
Biochemicals, Mannheim, Germany) was used to evaluate
cell death as described previously [12]. Percentage LDH
release was defined as [(A490–A650) of RIG1-cells/
(A490–A650) of control transfected cells] × 100%. Chro-
matin condensation was used as a measure of cellular
apoptosis. Briefly, cells in 6-cm dishes were transfected
with various plasmids for 48 h and then fixed with 4%
paraformaldehyde. After the cells were washed twice with
cold PBS, they were incubated at room temperature for 10
min with PBS containing 1 μg/ml Hoechst 33258 and 4%
bovine serum albumin. Chromatin condensation was
analyzed with an Olympus IX-70 immunofluorescent
microscope (Olympus, Glostrup, Denmark).
Measurement of caspase 3 activity
HtTA cells were transfected with recombinant RIG1
expression vectors or electroporated with wild type or
mutated DPs for 24 h. Cells were lysed in MLB containing
protease and phosphatase inhibitors. To measure the
activities of caspase-3, cell lysates were incubated at room
temperature for 12 h with buffer containing 25 mM
HEPES, pH 7.5, 0.1% CHAPS, 5% sucrose, 5 mM DTT, 2
mM EDTA, and 2 mM substrate for caspase-3 (Ac-DEVD-
pNA; Sigma). Absorbance at 405 nm was measured with a
microplate reader.
Abbreviations
DAPI: 4'6-diamidino-2-phenylindole; DP: dodecapep-
tide; EGFP: enhanced green fluorescence protein; FBS:
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red fluorescence protein; LRAT: lecithin:retinol acyltrans-
ferase; PBS: phosphate buffered saline; RIG1: Retinoid-
inducible gene 1; RIG1111–123: corresponding to amino
acids 112–123 located within the NC domain of RIG1.
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